<DOC>
	<DOCNO>NCT00544791</DOCNO>
	<brief_summary>Recent study describe role melatonin sleep regulator anti- oxidative neuroprotective agent improve sleep quality delay cognitive decline Alzheimer 's disease ( AD ) . In accordance data , hypothesis melatonin delay cognitive decline Mild Cognitive Impairment ( MCI ) patient reduce conversion rate MCI AD .</brief_summary>
	<brief_title>The Effect Melatonin Cognitive Function Patients Diagnosed With Mild Cognitive Impairment</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>1 . MCI assessment accord Peterson et al . ( 2001 ) criterion . 2 . Age 5590 year , inclusive . 3 . Study informant available . 4 . Mini Mental Status Examination ; MMSE 2430 . 5 . Adequate vision hear neuropsychological testing . 6 . Normal vitamin B12 level thyroid function . 1 . Significant cerebral vascular disease ( Modified Hachinski scale &gt; 4 ) . 2 . Depression ( Hamilton Depression Rating Scale &gt; 12 ) . 3 . Central nervous system infarct , infection focal lesion clinical significance CT MRI scan . 4 . Medical disease psychiatric disorder could interfere study participation . 5 . Pregnant , lactate childbearing potential . 6 . Taking vitamin supplement supplement . 7 . Restrictions concomitant medication usage , include significant cholinergic anticholinergic effect potential adverse effect cognition .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Melatonin</keyword>
	<keyword>Antioxidant</keyword>
	<keyword>Memory</keyword>
	<keyword>Alzheimer</keyword>
</DOC>